We could not find any results for:
Make sure your spelling is correct or try broadening your search.
CAMPBELL, Calif., Dec. 26, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (βAtrecaβ) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery...
SAN CARLOS, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | -0.139 | -48.0968858131 | 0.289 | 0.34 | 0.15 | 760832 | 0.25619961 | CS |
26 | -0.0862 | -36.4944961897 | 0.2362 | 0.4448 | 0.1023 | 5615013 | 0.26764818 | CS |
52 | -0.76 | -83.5164835165 | 0.91 | 1.2642 | 0.1023 | 2999995 | 0.29231329 | CS |
156 | -11.91 | -98.7562189055 | 12.06 | 12.73 | 0.1023 | 1316011 | 1.59613698 | CS |
260 | -19.75 | -99.2462311558 | 19.9 | 29.35 | 0.1023 | 878886 | 2.87270886 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions